BRL-42715

BRL-42715 is a potent inhibitor of a broad range of bacterial beta-lactamases (β-lactamase) [1].

Product Specifications

CAS Number

[102209-75-6]

UNSPSC

12352005

Target

Bacterial; Beta-lactamase

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/brl-42715.html

Solubility

10 mM in DMSO

Smiles

O=C(C(N1C/2=O)=CS[C@]1([H])C2=C/C3=CN(C)N=N3)O[Na]

Molecular Formula

C10H7N4NaO3S

Molecular Weight

286.24

References & Citations

[1]Coleman K, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.|[2]K Coleman, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.